TimesSquare Capital Management’s Guardant Health GH Stock Holding History

TimesSquare Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,400	Closed	-$228K	–	186
2022 Q4	$228K	Sell	8,400 -25,800	-75%	-$1.18M	﹤0.01%	177
2022 Q3	$1.84M	Sell	34,200 -15,000	-30%	-$770K	0.03%	178
2022 Q2	$1.99M	Sell	49,200 -304,300	-86%	-$15.1M	0.03%	181
2022 Q1	$23.4M	Hold	353,500	–	–	0.26%	142
2021 Q4	$35.4M	Sell	353,500 -36,100	-9%	-$3.73M	0.31%	134
2021 Q3	$48.7M	Buy	389,600 +89,450	+30%	+$10.6M	0.43%	99
2021 Q2	$37.3M	Buy	300,150 +34,925	+13%	+$4.7M	0.3%	138
2021 Q1	$40.5M	Buy	265,225 +58,425	+28%	+$8.83M	0.35%	126
2020 Q4	$26.7M	Buy	+206,800	New	+$23.8M	0.22%	163

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

TimesSquare Capital Management's GH Position: Q1 2023 in Review

TimesSquare Capital Management sold out of Guardant Health (GH) in Q1 2023, closing a stake of 8,400 shares — an estimated $228K sold.

TimesSquare Capital Management first reported a position in GH in Q4 2020 and held it in 9 quarters. The position peaked at $48.7M in Q3 2021. 279 funds tracked by Wall St. Rank hold GH as of Q1 2023.

TimesSquare Capital Management reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
TimesSquare Capital Management sold 8,400 Guardant Health shares in Q1 2023, an estimated $228K.
TimesSquare Capital Management first reported a position in Guardant Health in Q4 2020 and held it in 9 quarters.
TimesSquare Capital Management's Guardant Health position peaked at $48.7M in Q3 2021.
279 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on TimesSquare Capital Management's 13F filing for Q1 2023, filed 10 May 2023.